Innovation in drug delivery broad-based proprietary
1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Innovation in Drug Delivery - Broad-based Proprietary
Technology Platforms to Address Delivery Efficiency and
Improve Patient Compliance
You can also request for sample page of above mention reports on
sample@aarkstore.com
GBI Research, the leading business intelligence provider, has released its latest
research, “Innovation in Drug Delivery - Broad-based Proprietary Technology
Platforms to Address Delivery Efficiency and Improve Patient Compliance”. The
report provides an overview of the most exciting innovations in drug delivery
technologies in major therapeutic areas – oncology, vaccines, diabetes,
rheumatology and respiratory diseases. Each chapter highlights emerging
companies with technologies that have the potential to transform drug delivery in
that specific therapeutic area. The report also explores the current environment in
healthcare and the pharmaceutical industry, and examines drivers and challenges
for the use of innovative drug delivery technologies. Drug delivery technologies
provide commercial opportunities for pharmaceutical companies by improving the
chances of success for a drug development project. They enable the formulation of a
promising molecule that might have poor solubility or require selective delivery to a
particular tissue, such as the brain. Similarly, drug delivery technologies may enable
companies to differentiate products within crowded therapeutic areas, facilitate life
cycle management for existing drugs, and reposition existing drugs – proprietary or
generic – in new indications where the needs of the patient population are different
or, again, where more targeted delivery is required. Products that are reformulated
with novel drug delivery systems do not meet the traditional criteria for innovative
products – in other words, products that include new active moieties. Nevertheless,
GBI Research’s analysis shows that the commercial success of existing products that
rely on innovative drug delivery technologies is clear, and these products make
2. significant positive changes for patients.
Table of contents:
1.1 List of Tables
1.2 List of Figures
2 Executive Summary
2.1 Drug Delivery Requirements Vary Across Therapeutic Areas
2.2 Successful Drug Delivery Technologies Meet Patient Needs
3 Drug Delivery: An Overview
3.1 Introduction
3.2 The Drug Delivery Market
3.3 Market Trends Affecting Drug Delivery
3.3.1 Drivers within the Healthcare Environment
3.3.2 Pharmaceutical Industry
3.4 Leading Drug Delivery Companies
3.4.1 Pharmaceutical Company Drug Delivery Portfolios
3.4.2 Deal Making
3.5 GBI Research Report Guidance
4 Oncology
4.1 Introduction
4.2 PEGylation
4.3 Protein-Based Drug Delivery Systems
4.3.1 Albumin
4.3.2 Other Fusion Proteins
4.3.3 Hyaluronidase
4.4 Nanoparticles for Drug Delivery
4.4.1 Liposomes
4.4.2 Dendrimers
4.4.3 Polymer Delivery Systems
4.5 Tumor Targeting
4.5.1 Antibody-Drug Conjugates
4.6 Conclusions
3. List of Figures
List of Tables are also include.
For more Reports Plz follow The link:
Pharmaceutical Pricing and Reimbursement - Adoption of Health Technology
Assessments (HTA) Optimizes Drug Pricing and Accelerates Reimbursement
Decision-Making
Pharmaceutical Supply Chain in Japan - Periodic Drug Price Revisions by National
Health Insurance Increase Competition and Squeeze Profit Margins
Retail Clinics - 2012 Yearbook
Engaging Key Opinion Leaders (KOLs) - Identifying and Leveraging New KOL
Groups to Drive Medical Marketing Strategy
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/market-sector-reports/Pharmaceuticals-&-Healthcare-
7.html
For More details Plz do contact :
Aarkstore Enterprise
